Integra LifeSciences
Integra LifeSciences Announces Leadership Transition Plan
February 28, 2024 06:00 ET | Integra LifeSciences Holdings Corporation
Jan De Witte to retire as CEO by the end of 2024Stuart Essig appointed executive chairman of the Board PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings...
Integra LifeSciences
Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
February 28, 2024 06:00 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31,...
Integra LifeSciences
Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
February 07, 2024 09:15 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year...
Integra LifeSciences
Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 05, 2024 16:30 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president...
Integra LifeSciences
Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®
December 13, 2023 06:15 ET | Integra LifeSciences Holdings Corporation
The acquisition will become part of Integra’s Codman Specialty Surgical (CSS) division. The ear, nose and throat (ENT) category is a key area of strategic interest and highly complementary to the...
Jeff Graves
Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of Directors
December 12, 2023 12:00 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Jeff Graves, Ph.D.,...
Integra LifeSciences
Integra LifeSciences Reports Third Quarter 2023 Financial Results
October 25, 2023 06:00 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...
Integra LifeSciences
Integra LifeSciences to Host Third Quarter 2023 Financial Results Conference Call on October 25, 2023
October 04, 2023 08:00 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2023 financial...
Integra LifeSciences
Integra LifeSciences to Present at the 2023 Wells Fargo Healthcare Conference
September 01, 2023 17:04 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief...
Integra LifeSciences
Integra LifeSciences Reports Second Quarter 2023 Financial Results
July 26, 2023 18:30 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...